
Cencora Inc. (COR), a large-cap growth stock in the Major Drugs industry, received an 81% rating from Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy. This score indicates "some interest" from the model, which prioritizes low volatility, strong momentum, and high net payout yields. While COR passed market capitalization and standard deviation criteria, its momentum and net payout yield metrics were neutral within the strategy's framework.
Cencora Inc. (COR), a large-cap growth stock in the Major Drugs industry, presents a mixed profile according to Validea's quantitative analysis based on Pim van Vliet's low-risk investment model. The stock received an 81% rating, signifying a degree of interest from the model, which prioritizes low volatility, strong momentum, and high net payout yield. COR successfully meets the strategy's criteria for market capitalization and low standard deviation, aligning with the core defensive tenets of the van Vliet approach. However, its performance on other key factors is notably weaker, with both its 'Twelve Minus One Momentum' and 'Net Payout Yield' assessed as 'NEUTRAL'. This indicates that the stock's recent price appreciation and shareholder return profile are not compelling enough to be considered strengths under this specific framework. Critically, despite the relatively high 81% score, the security ultimately receives a 'FAIL' on its 'FINAL RANK', suggesting that while it possesses some attractive low-volatility characteristics, it does not fully meet the holistic requirements for a complete endorsement by this multi-factor strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment